Related Experiment Video
Updated: Sep 18, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Bullous Pemphigoid: Clinical Aspects and Treatments
Ryan S Q Geng1, R Gary Sibbald
1Ryan S. Q. Geng, MSc, is Medical Student, Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada. R. Gary Sibbald, MD, MEd, FRCPC, MACP, MAPWCA, JM, is Professor of Medicine and Public Health, Dalla Lana School of Public Health & Division of Dermatology, Department of Medicine, University of Toronto.
General Purpose:
To review the risk factors and clinical features of bullous pemphigoid (BP) and discuss available treatment options.
Target Audience:
This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses with an interest in skin and wound care.
Learning Objectives/Outcomes:
After participating in this educational activity, the participant will: 1. Summarize the clinical features and manifestations associated with BP. 2. Identify evidence-based methods to diagnose BP. 3. Explain evidence-based pharmacologic management strategies for the effective treatment of BP.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

